These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 9050293)

  • 1. Hepatitis and hepatitis immunisation.
    Feely M
    J R Soc Health; 1997 Feb; 117(1):41-6. PubMed ID: 9050293
    [No Abstract]   [Full Text] [Related]  

  • 2. Morbidity from hepatitis B after introduction of nationwide immunisation in Italy.
    Squarcione S; Pompa MG; Vellucci L
    Lancet; 1997 Jul; 350(9071):114. PubMed ID: 9228969
    [No Abstract]   [Full Text] [Related]  

  • 3. Hepatitis B vaccines.
    Wkly Epidemiol Rec; 2009 Oct; 84(40):405-19. PubMed ID: 19817017
    [No Abstract]   [Full Text] [Related]  

  • 4. Assessing the safety of hepatitis B vaccination during pregnancy in the Vaccine Adverse Event Reporting System (VAERS), 1990-2016.
    Moro PL; Zheteyeva Y; Barash F; Lewis P; Cano M
    Vaccine; 2018 Jan; 36(1):50-54. PubMed ID: 29174107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety of currently licensed hepatitis B surface antigen vaccines in the United States, Vaccine Adverse Event Reporting System (VAERS), 2005-2015.
    Haber P; Moro PL; Ng C; Lewis PW; Hibbs B; Schillie SF; Nelson NP; Li R; Stewart B; Cano MV
    Vaccine; 2018 Jan; 36(4):559-564. PubMed ID: 29241647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Foreword. Hepatitis B and the impact of immunization in China and the WHO Western Pacific Region.
    Yu W
    Vaccine; 2013 Dec; 31 Suppl 9():J2. PubMed ID: 24331016
    [No Abstract]   [Full Text] [Related]  

  • 7. Adverse events after hepatitis A B combination vaccine.
    Woo EJ; Miller NB; Ball R;
    Vaccine; 2006 Mar; 24(14):2685-91. PubMed ID: 16310295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) Part II: immunization of adults.
    Mast EE; Weinbaum CM; Fiore AE; Alter MJ; Bell BP; Finelli L; Rodewald LE; Douglas JM; Janssen RS; Ward JW;
    MMWR Recomm Rep; 2006 Dec; 55(RR-16):1-33; quiz CE1-4. PubMed ID: 17159833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dancing fascicles--a new signal related to hepatitis B immunization.
    Adhisivam B; Bhat BV
    Indian J Pediatr; 2015 Apr; 82(4):387. PubMed ID: 25416090
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunisation against hepatitis B.
    Greensmith AL
    N Z Dent J; 1995 Jun; 91(404):69-70. PubMed ID: 7675351
    [No Abstract]   [Full Text] [Related]  

  • 11. Statement on hepatitis B vaccine. National Advisory Committee on Immunization.
    CMAJ; 1993 Nov; 149(10):1465-80. PubMed ID: 8221430
    [No Abstract]   [Full Text] [Related]  

  • 12. [Viral hepatitis: preventable illnesses].
    Baumgarten R
    Z Arztl Fortbild Qualitatssich; 1998 Dec; 92(10):677-80. PubMed ID: 10028595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A two-dose hepatitis B vaccine for adults (Heplisav-B).
    Med Lett Drugs Ther; 2018 Jan; 60(1539):17-18. PubMed ID: 29364196
    [No Abstract]   [Full Text] [Related]  

  • 14. [Hepatitis B, systematic vaccination and new recommendations].
    Girault V
    Presse Med; 2002 Jun; 31(23):1059. PubMed ID: 12148261
    [No Abstract]   [Full Text] [Related]  

  • 15. Hepatitis B immunisation programmes in European Union, Norway and Iceland: where we were in 2009?
    Mereckiene J; Cotter S; Lopalco P; D'Ancona F; Levy-Bruhl D; Giambi C; Johansen K; Dematte L; Salmaso S; Stefanoff P; O'Flanagan D
    Vaccine; 2010 Jun; 28(28):4470-7. PubMed ID: 20451643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implementing immunization program efficiently, and establishing national database of adverse reactions.
    Gao GF
    Sci China Life Sci; 2014 May; 57(5):553-4. PubMed ID: 24526494
    [No Abstract]   [Full Text] [Related]  

  • 17. Hepatitis B immunisation leads to the decline of hepatitis B virus prevalence in Gansu province, China.
    Liu C; Li H; Gao L; Li F; Liang X; Yang K
    Aust N Z J Public Health; 2011 Feb; 35(1):91-2. PubMed ID: 21299712
    [No Abstract]   [Full Text] [Related]  

  • 18. Report of the Hepatitis B Working Group.
    Can Commun Dis Rep; 1994 Jul; 20(13):105-12. PubMed ID: 7920361
    [No Abstract]   [Full Text] [Related]  

  • 19. Intramuscular versus intradermal administration of anti-hepatitis B vaccine in non-cirrhotic hepatitis C patients.
    Arbizu EA; Marugán RB; Grijalba JY; Serrano PL; Grande LG; Del Campo Terrón S
    Vaccine; 2003 Jun; 21(21-22):2747-50. PubMed ID: 12798613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A case-series of adverse events, positive re-challenge of symptoms, and events in identical twins following hepatitis B vaccination: analysis of the Vaccine Adverse Event Reporting System (VAERS) database and literature review.
    Geier MR; Geier DA
    Clin Exp Rheumatol; 2004; 22(6):749-55. PubMed ID: 15638050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.